About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 23, 2020... Dr. Nir London of the Weizmann Institute’s Department of Organic Chemistry explains his lab’s approach to fighting the coronavirus: creating a novel antiviral treatment. After identifying candidates for an antibody, he and his team are designing second-generation compounds that will go to colleagues in Germany and the U.K. for testing against the virus. Dr. London emphasizes the fact that this is open science: research that is freely available to all, for the benefit of everyone.
Mar 19, 2020... “This is the most important thing I can do,” says the Weizmann Institute’s Prof. Sarel Fleishman. His lab in the Department of Biomolecular Sciences was already studying SARS, which is, like COVID-19, a coronavirus. He is able to quickly apply his knowledge to developing computer models that allow him to design coronavirus antibodies – work that could lead to a vaccine.
Mar 19, 2020... In this videoconference, the Weizmann Institute’s Dr. Ron Diskin of the Department of Structural Biology, an expert in animal-borne viruses such as coronavirus, shares his insights on the current pandemic. A Q&A session with participants follows.
https://www.weizmann-usa.org/news-media/news-releases/two-steps-ahead-of-the-coronavirus/
Mar 22, 2020... REHOVOT, ISRAEL—March 22, 2020—A method for monitoring, identifying, and predicting where the coronavirus will spread has attracted considerable international interest. It was initiated and developed by scientists from the Weizmann Institute of Science, in collaboration with researchers from the Hebrew University of Jerusalem and Clalit Health Services and in coordination with Israel’s Ministry of Health. Other governments have now begun to implement the method, which is based on questionnaires for the general public and analysis of the data obtained from them. The questionnaires track the development of virus-induced symptoms, and the analysis relies on Big Data algorithms and artificial intelligence. Viral spread occurs in clusters of infection; thus, early identification of clusters may facilitate various actions aimed at slowing down the spread of the virus.
Mar 25, 2020... In this videoconference hosted by Weizmann Canada, Prof. Sarel Fleishman of the Weizmann Institute’s Department of Biomolecular Sciences gives a progress report on his lab’s coronavirus research. The coronavirus is so named because it is covered in “spikes” that look like the sun’s corona; Prof. Fleishman seeks to bind and neutralize the spike proteins, thus stopping the virus.
Mar 16, 2020... Prof. Gabi Barbash, Former Director General of Israel’s Ministry of Health and Director of the Weizmann Institute Bench-to-Bedside Program, which brings together scientists and physicians to fight disease, explains coronavirus from the perspective of public health. He also speaks to how it spreads and how it is different from other contagions.
Mar 25, 2020... In just one week, Profs. Ido Amit and Eran Elinav, both of the Department of Immunology, have built one of the highest-tech labs in the world. They developed a new type of PCR testing that is tremendously fast: if current capabilities test one patient at a time, the new method can test all of Israel simultaneously. The scientists intend to make their method available to anyone who needs it.
Mar 19, 2020... Dr. Noam Stern-Ginossar of the Weizmann Institute’s Department of Molecular Genetics provides an overview – complete with helpful cartoons – of basic questions: what is a virus? Why is coronavirus worse than the flu? (One reason – it’s new and so we have no immunity.) What are the issues related to developing a vaccine? (Mostly it’s time; otherwise, we know what to do, she reassures us.)
May 08, 2020...
It started with a tweet. Alpha Lee, co-founder and chief scientific officer of machine-learning company PostEra, read on Twitter that Diamond Light Source, the UK’s national synchrotron facility, had identified a set of chemical fragments that attach to an important coronavirus protein.
Lee wondered if his company, formed just six months earlier, could help connect the dots from fragments to viable drugs to fight COVID-19. PostEra uses AI algorithms to map routes for drug synthesis to speed the drug discovery process. But to do so, they would need some design ideas. So Lee asked the Internet.
https://www.weizmann-usa.org/news-media/news-releases/the-self-synthesizing-ribosome/
Apr 20, 2020... REHOVOT, ISRAEL—April 20, 2020—As the cell’s protein factory, the ribosome is the only natural machine that manufactures its own parts. That’s why understanding how the machine itself is made could unlock the door to everything from understanding how life develops to designing new methods of drug production. An intensive research effort at the Weizmann Institute of Science has now demonstrated the self-synthesis and assembly of the small subunit of a ribosome – 30S – on a surface of a chip. The findings were published in Science Advances.
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR